- /
- Supported exchanges
- / US
- / CODX.NASDAQ
Co-Diagnostics, Inc. Common Stock (CODX NASDAQ) stock market data APIs
Co-Diagnostics, Inc. Common Stock Financial Data Overview
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Co-Diagnostics, Inc. Common Stock (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Co-Diagnostics, Inc. Common Stock data using free add-ons & libraries
Get Co-Diagnostics, Inc. Common Stock Fundamental Data
Co-Diagnostics, Inc. Common Stock Fundamental data includes:
- Net Revenue: 721 K
- EBITDA: -29 090 594
- Earnings Per Share: -25
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Co-Diagnostics, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-08-13
- EPS/Forecast: -3
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Co-Diagnostics, Inc. Common Stock News
New
Co-Dx (CODX) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Thursday, Aug. 13, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Head of Investor Relations-Andrew Benson Chief Executive Officer-Dwight H. Egan Chief Financial Office...
Co-Diagnostics outlines FDA dual 510(k) and CLIA waiver submission as cash falls to $3.6M
Earnings Call Insights: Co-Diagnostics (CODX) Q2 2026 MANAGEMENT VIEW * Dwight Egan (Chairman, CEO & President) framed Q2 as “another important step in our transition from platform development t...
Co-Diagnostics And CoSara Advance Development Of Ebola PCR Test And Point-of-Care Platform; Stock Up
(RTTNews) - Co-Diagnostics Inc. (CODX) and its joint venture CoSara Diagnostics Pvt. Ltd. announced progress in developing a PCR-based diagnostic test for Ebola virus, alongside enhancements to the Co...
Pre Market Movers: GNTA, HCWC, ZCMD Set The Path
(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday, suggesting potential breakout opportunities. Assessing sentiment and momentum in the premarket sets the tone for ...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.